A Prospective Observational Study Evaluating the Efficacy of Omalizumab and Mepolizumab in Patients With Severe Asthma. [PDF]
Makhlooq M +6 more
europepmc +1 more source
Combined biologic therapy targeting B cells and eosinophils in relapsing multiple sclerosis and severe asthma: a case report of ofatumumab and mepolizumab. [PDF]
Zanghì A +4 more
europepmc +1 more source
Tezepelumab After Mepolizumab in Allergic Bronchopulmonary Mycosis: A Case Report. [PDF]
Oda N +7 more
europepmc +1 more source
More Than Five Years of Sustained Remission With Mepolizumab in Adolescent-Onset Eosinophilic Granulomatosis With Polyangiitis: A Case Report. [PDF]
Araya T +4 more
europepmc +1 more source
Recent Developments in Monoclonal-Antibody-Based Biologic Therapy for Severe Refractory Eosinophilic Asthma. [PDF]
Walsh GM.
europepmc +1 more source
Clinical Remission and Its Determinants in Adult Severe Asthma Patients Receiving Biologic Therapy: A Retrospective Analysis. [PDF]
Ediger D +3 more
europepmc +1 more source
Can Coexisting Allergic Rhinitis in Patients with Severe Eosinophilic Asthma Be a Prognostic Factor for Efficacy of Biological Therapy? Analysis of Eosinophilic Involvement. [PDF]
Jura-Szołtys E +3 more
europepmc +1 more source
Distinct Effects of Biological Treatments on Eosinophils and Neutrophils in Chronic Rhinosinusitis With Nasal Polyp Patients. [PDF]
Van Nevel S +10 more
europepmc +1 more source
Identification of key genes predicting the efficacy of mepolizumab in the treatment of severe eosinophilic asthma. [PDF]
Xinmin P, Jinxia C, Fengyuan L.
europepmc +1 more source

